Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical asset in kidney disease, today announces that the ACTION3 Phase 3 trial of DMX-200 in patients with focal segmental ...
After so many run-ins with the law, it makes sense for DMX to release a recored titled "Change Is Gonna Come." For his sake, we hope so. Listen to Earl singing about progress on the latest ...
Syncsort, a leader in data liberation, integrity and integration solutions for next-generation analytics, announced new capabilities in its unrivaled mainframe data access and integration solution ...
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Syncsort, a global leader in data liberation, integrity and integration solutions for next-generation analytics, today announced new capabilities in its unrivaled ...